Kardi Ai is set to enter the Indian market with its AI-powered long-term cardiac monitoring technology, with the official launch scheduled for September 26 in Hyderabad.

The launch was announced by Dr. Ramana Jagarlamudi, Director – International Operations and Authorised Representative – India, Kardi Ai, and Dr. Raghavendra Rao, Scientific Adviser and Co-founder, Eurasia Medical Technologies LLP, during a press conference held at the Federation of Telangana Chambers of Commerce and Industry (FTCCI).

The India launch will bring together cardiologists, electrophysiologists, physicians, hospital leaders, healthcare technology professionals and other stakeholders to discuss developments in long-term rhythm monitoring, remote cardiac care and AI-supported ECG analysis.

The programme will include clinical sessions covering cardiac arrhythmias, their detection and diagnosis, the clinical value of long-term ECG monitoring and the application of Kardi Ai technology in clinical practice. A panel discussion will precede the official launch.

Kardi Ai is designed to extend the cardiac monitoring window by enabling physicians to access ECG data collected over longer periods. The technology is intended to support the identification of intermittent cardiac rhythm abnormalities that may not be detected during shorter monitoring periods.

The India launch will be held under the theme “From Signal to Insight for Healthier Lives”, highlighting the potential role of long-term ECG monitoring, remote cardiac care and artificial intelligence in cardiovascular healthcare.

Cardiovascular disease remains a major healthcare challenge in India, increasing the importance of early identification and continuous monitoring of cardiac abnormalities. According to the World Health Organization (WHO), around 220 million people in India are estimated to have hypertension, a major cardiovascular risk factor, while approximately 12 percent have their blood pressure under control.